Cumberland Stock Soars 90% After FDA Approval for Acetadote Dosing Change
FDA approval of Acetadote's simplified dosing propels Cumberland Pharmaceuticals' stock to a 90% single-day surge ...
Monthly Prescribing Reference1d
New Dosing Regimen for APAP Overdose Antidote Acetadote Approved
The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in ...
Hosted on MSN1d
Cumberland Pharma Stock Hits 16-Month High After FDA Approves Liver Drug Regimen: Retail’s Thrilled
Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following ...
UniQure Stock Doubles After Striking A Deal With The FDA For Huntington's Drug
UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease ...
bovnews1d
Cumberland Pharmaceuticals (CPIX) Soars in Premarket Trading on FDA Approval
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a Tennessee-based specialty pharmaceutical company, saw its stock price surge by a remarkable 95.96% to $2.43 in Tuesday’s premarket trading session.
FDA Approves Cumberland's New Dosing Regimen For Acetadote In Acetaminophen Overdose Treatment
Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company, Tuesday, announced that its supplemental New Drug ...
Cumberland Pharma Shares Rise 56% After FDA Approves Liver Drug Acetadote
Shares of Cumberland Pharmaceuticals were trading higher in the after-hours market after the company said the Food and Drug Administration approved a supplemental new drug application for liver drug ...
Cumberland announces FDA approves sNDA for Acetadote product
Pharmaceuticals announced the FDA has approved a supplemental New Drug Application for its Acetadote product. Acetadote is an ...
FDA APPROVES ACETADOTE® sNDA
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a ...